|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing deposits in banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Securities available for sale | ||||||||||||||||||||
| Securities held to maturity (fair value of $34,896 and $46,280, respectively) | ||||||||||||||||||||
| Loans, net of allowance of $13,030 and $11,531, respectively | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Premises held for sale | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Federal Home Loan Bank stock | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Deferred taxes, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Accrued interest receivable and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Non-interest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Junior subordinated debentures | ||||||||||||||||||||
| Subordinated capital notes | ||||||||||||||||||||
| Senior debt | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingent liabilities (Note 15) | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Common stock, no par, 39,000,000 shares authorized, 6,594,749 and 6,498,865 voting, and 1,000,000 and 1,000,000 non-voting shares issued and outstanding, respectively | ||||||||||||||||||||
| Common stock, no par, 39,000,000 shares authorized, 6,638,633 and 6,594,749 voting, and 1,000,000 and 1,000,000 non-voting shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total common stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
